An Entity of Type: vaccine, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

NmVac4-A/C/Y/W-135 is the commercial name of the polysaccharide vaccine against the bacterium (specifically serogroups A, C, Y, and W-135) that causes meningococcal meningitis. The product, by JN-International Medical Corporation, is designed and formulated to be used in developing countries for protecting populations during meningitis disease epidemics.

Property Value
dbo:abstract
  • NmVac4-A/C/Y/W-135 is the commercial name of the polysaccharide vaccine against the bacterium (specifically serogroups A, C, Y, and W-135) that causes meningococcal meningitis. The product, by JN-International Medical Corporation, is designed and formulated to be used in developing countries for protecting populations during meningitis disease epidemics. Meningococcal meningitis is a bacterial infection caused by the bacterium Neisseria meningitidis, also known as meningococcus. The vaccine is made from bacterial capsular polysaccharides through fermentation of each individual serogroup of Neisseria meningitidis in bioreactors. After fermentation, the polysaccharides are purified, formulated, and lyophilized using preservatives and stabilizers to make a vaccine product. The vaccine cannot protect from other serogroups of N. meningitidis and cannot eliminate the chance of infection by these serogroups. (en)
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 20547586 (xsd:integer)
dbo:wikiPageLength
  • 22944 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1101519541 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • J07 (en)
dbp:atcSuffix
  • AH04 (en)
dbp:chemspiderid
  • none (en)
dbp:pregnancyUs
  • C (en)
dbp:routesOfAdministration
  • Intramuscular (en)
dbp:target
  • Neisseria meningitidis A,C,Y,W-135 (en)
dbp:type
  • vaccine (en)
dbp:vaccineType
  • polysaccharide (en)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 444518343 (xsd:integer)
dbp:width
  • 50 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • NmVac4-A/C/Y/W-135 is the commercial name of the polysaccharide vaccine against the bacterium (specifically serogroups A, C, Y, and W-135) that causes meningococcal meningitis. The product, by JN-International Medical Corporation, is designed and formulated to be used in developing countries for protecting populations during meningitis disease epidemics. (en)
rdfs:label
  • NmVac4-A/C/Y/W-135 (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License